710 related articles for article (PubMed ID: 33346905)
1. The role of the gut microbiome and its metabolites in metabolic diseases.
Wu J; Wang K; Wang X; Pang Y; Jiang C
Protein Cell; 2021 May; 12(5):360-373. PubMed ID: 33346905
[TBL] [Abstract][Full Text] [Related]
2. [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].
Bischoff SC
Internist (Berl); 2017 May; 58(5):441-448. PubMed ID: 28432400
[TBL] [Abstract][Full Text] [Related]
3. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
Rajani C; Jia W
Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
[TBL] [Abstract][Full Text] [Related]
4. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
Panasevich MR; Peppler WT; Oerther DB; Wright DC; Rector RS
Physiol Genomics; 2017 Aug; 49(8):385-399. PubMed ID: 28600319
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
6. Gut microbial metabolites in obesity, NAFLD and T2DM.
Canfora EE; Meex RCR; Venema K; Blaak EE
Nat Rev Endocrinol; 2019 May; 15(5):261-273. PubMed ID: 30670819
[TBL] [Abstract][Full Text] [Related]
7. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.
Jayakumar S; Loomba R
Aliment Pharmacol Ther; 2019 Jul; 50(2):144-158. PubMed ID: 31149745
[TBL] [Abstract][Full Text] [Related]
8. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.
Sanduzzi Zamparelli M; Compare D; Coccoli P; Rocco A; Nardone OM; Marrone G; Gasbarrini A; Grieco A; Nardone G; Miele L
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483246
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
10. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function.
Sharpton SR; Ajmera V; Loomba R
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):296-306. PubMed ID: 30196156
[TBL] [Abstract][Full Text] [Related]
11. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota, obesity and metabolic disorders.
Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.
Aron-Wisnewsky J; Vigliotti C; Witjes J; Le P; Holleboom AG; Verheij J; Nieuwdorp M; Clément K
Nat Rev Gastroenterol Hepatol; 2020 May; 17(5):279-297. PubMed ID: 32152478
[TBL] [Abstract][Full Text] [Related]
14. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
[TBL] [Abstract][Full Text] [Related]
15. Role of gut microbial metabolites in nonalcoholic fatty liver disease.
Zhao ZH; Lai JK; Qiao L; Fan JG
J Dig Dis; 2019 Apr; 20(4):181-188. PubMed ID: 30706694
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and its metabolic potential.
Czajkowska A; Kaźmierczak-Siedlecka K; Jamioł-Milc D; Gutowska I; Skonieczna-Żydecka K
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12971-12977. PubMed ID: 33378048
[TBL] [Abstract][Full Text] [Related]
17. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.
Jennison E; Byrne CD
Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863
[TBL] [Abstract][Full Text] [Related]
18. Microbiota and Aging.
Lu M; Wang Z
Adv Exp Med Biol; 2018; 1086():141-156. PubMed ID: 30232757
[TBL] [Abstract][Full Text] [Related]
19. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiota and metabolic disease: current understanding and future perspectives.
Arora T; Bäckhed F
J Intern Med; 2016 Oct; 280(4):339-49. PubMed ID: 27071815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
